Top

Sleep and Breathing

Published in:

01-12-2020 | Human Immunodeficiency Virus | Sleep Breathing Physiology and Disorders • Review

Metabolomics of sleep disorders in HIV: a narrative review

Authors: Monique Balthazar, Idiatou Diallo, Victoria M. Pak

Published in: Sleep and Breathing | Issue 4/2020

Abstract

Purpose

Sleep disturbances are prevalent among patients with human immunodeficiency virus (HIV), even those who are being treated on antiretroviral therapy. It is important to understand the metabolomic mechanisms underlying sleep disturbances among people living with HIV (PLWH).

Methods

A review of recent literature was performed to explore the use of metabolomics in understanding sleep among PLWH.

Results

We found only two studies that used metabolomics to explore sleep health among PLWH.

Conclusion

This paper reviews common sleep disorders in HIV, the existing metabolomic studies that may explain the relationship, and implications for future research. The use of metabolomics in exploring sleep disorders among PLWH will help to elucidate mechanistic links to improve patient outcomes.

Clish CB (2015) Metabolomics: an emerging but powerful tool for precision medicine. Molecular Case Studies 1(1):a000588CrossRef

Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E (2012) HMDB 3.0—the human metabolome database in 2013. Nucleic Acids Res 41(D1):D801–D807CrossRef

Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, Walsh MC, Berden JA, Brindle KM, Kell DB, Rowland JJ (2001) A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 19(1):45–50CrossRef

Wibbeler T, Reichelt D, Husstedt I-W, Evers S (2012) Sleepiness and sleep quality in patients with HIV infection. J Psychosom Res 72(6):439–442CrossRef

Taibi DM, Price C, Voss J (2013) A pilot study of sleep quality and rest–activity patterns in persons living with HIV. J Assoc Nurses AIDS Care 24(5):411–421CrossRef

Salahuddin N, Barroso J, Leserman J, Harmon JL, Pence BW (2009) Daytime sleepiness, nighttime sleep quality, stressful life events, and HIV-related fatigue. J Assoc Nurses AIDS Care 20(1):6–13CrossRef

Redman K, Karstaedt A, Scheuermaier K (2018) Increased CD4 counts, pain and depression are correlates of lower sleep quality in treated HIV positive patients with low baseline CD4 counts. Brain Behav Immun 69:548–555CrossRef

Bailey SM, Udoh US, Young ME (2014) Circadian regulation of metabolism. J Endocrinol 222 (2):R75-R96

Bell LN, Kilkus JM, Booth JN III, Bromley LE, Imperial JG, Penev PD (2013) Effects of sleep restriction on the human plasma metabolome. Physiol Behav 122:25–31CrossRef

10.

Xiao Q, Derkach A, Moore SC, Zheng W, Shu X-O, Gu F, Caporaso NE, Sampson JN, Matthews CE (2017) Habitual sleep and human plasma metabolomics. Metabolomics 13(5):63CrossRef

11.

Rubinstein ML, Selwyn PA (1998) High prevalence of insomnia in an outpatient population with HIV infection. Acquired Immunodeficiency Syndromes and Human Retrovirology 19:260–265CrossRef

12.

Wu J, Wu H, Lu C, Guo L, Li P (2015) Self-reported sleep disturbances in HIV-infected people: a meta-analysis of prevalence and moderators. Sleep Med 16(8):901–907. https://doi.org/10.1016/j.sleep.2015.03.027

13.

Crum-Cianflone NF, Roediger MP, Moore DJ, Hale B, Weintrob A, Ganesan A, Eberly LE, Johnson E, Agan BK, Letendre S (2012) Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis 54(10):1485–1494. https://doi.org/10.1093/cid/cis192CrossRefPubMedPubMedCentral

14.

Lee KA, Gay C, Portillo CJ, Coggins T, Davis H, Pullinger CR, Aouizerat BE (2012) Types of sleep problems in adults living with HIV/AIDS. J Clin Sleep Med 8(01):67–75CrossRef

15.

Lee KA, Gay C, Portillo CJ, Coggins T, Davis H, Pullinger CR, Aouizerat BE (2009) Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics. J Pain Symptom Manag 38(6):882–893CrossRef

16.

Kenedi CA, Goforth HW (2011) A systematic review of the psychiatric side-effects of efavirenz. AIDS Behav 15(8):1803–1818CrossRef

17.

Omonuwa TS, Goforth HW, Preud’homme X, Krystal AD (2009) The pharmacologic management of insomnia in patients with HIV. J Clin Sleep Med 5(03):251–262CrossRef

18.

Saberi P, Neilands TB, Johnson MO (2011) Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDs 25(9):517–524CrossRef

19.

Gutierrez J, Tedaldi EM, Armon C, Patel V, Hart R, Buchacz K (2019) Sleep disturbances in HIV-infected patients associated with depression and high risk of obstructive sleep apnea. SAGE Open Medicine 7:205031211984226

20.

Seay JS, McIntosh R, Fekete EM, Fletcher MA, Kumar M, Schneiderman N, Antoni MH (2013) Self-reported sleep disturbance is associated with lower CD4 count and 24-h urinary dopamine levels in ethnic minority women living with HIV. Psychoneuroendocrinology 38(11):2647–2653. https://doi.org/10.1016/j.psyneuen.2013.06.022

21.

Grandner MA (2014) Addressing sleep disturbances: An opportunity to prevent cardiometabolic disease?. International Review of Psychiatry 26 (2):155–176

22.

Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wi St, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD (2014) Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. The Lancet 384 (9939):241–248

23.

Cardinali DP, Esquifino AI (2012) Sleep and the immune system. Curr Immunol Rev 8(1):50–62CrossRef

24.

Ahmed D, Roy D, Cassol E (2018) Examining relationships between metabolism and persistent inflammation in HIV patients on antiretroviral therapy. Mediat Inflamm 2018

25.

Vgontzas AN, Zoumakis E, Bixler EO, Lin H-M, Follett H, Kales A, Chrousos GP (2004) Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. The Journal of Clinical Endocrinology & Metabolism 89(5):2119–2126CrossRef

26.

Irwin M (2002) Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun 16(5):503–512CrossRef

27.

Wilk A, Urbanska K, Yang S, Ying Wang J, Amini S, Del Valle L, Peruzzi F, Meggs L, Reiss K (2011) Insulin-like growth factor-I–forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-α-mediated neuronal damage: implications for human immunodeficiency virus encephalitis. J Neurosci Res 89(2):183–198CrossRef

28.

Leserman J, Barroso J, Pence B, Salahuddin N, Harmon J (2008) Trauma, stressful life events and depression predict HIV-related fatigue. AIDS Care 20(10):1258–1265CrossRef

29.

Burgess HJ, Weber KM, Burke-Miller J, McClellan L, Daubert E, Bond C, Morack R, Cohen M, French A (2019) 0849 sleep disturbance in women with and without HIV: the role of psychosocial factors. Sleep 42 (Supplement_1):A340-A341

30.

Jean-Louis G, Weber KM, Aouizerat BE, Levine AM, Maki PM, Liu C, Anastos KM, Milam J, Althoff KN, Wilson TE (2012) Insomnia symptoms and HIV infection among participants in the Women's interagency HIV study. Sleep 35(1):131–137. https://doi.org/10.5665/sleep.1602CrossRefPubMedPubMedCentral

31.

Oshinaike O, Akinbami A, Ojelabi O, Dada A, Dosunmu A, John Olabode S (2014) Quality of sleep in an HIV population on antiretroviral therapy at an urban tertiary Centre in Lagos, Nigeria. Neurology Research International 2014:6. https://doi.org/10.1155/2014/298703CrossRef

32.

Gallego L, Barreiro P, del Rio R, Gonzalez de Requena D, Rodriguez-Albarino A, Gonzalez-Lahoz J, Soriano V (2004) Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38(3):430–432. https://doi.org/10.1086/380791CrossRef

33.

Shikuma CM, Kohorn L, Paul R, Chow DC, Kallianpur KJ, Walker M, Souza S, Gangcuangco LMA, Nakamoto BK, Pien FD, Duerler T, Castro L, Nagamine L, Soll B (2018) Sleep and neuropsychological performance in HIV+ subjects on efavirenz-based therapy and response to switch in therapy. HIV Clinical Trials 19(4):139–147. https://doi.org/10.1080/15284336.2018.1511348CrossRefPubMedPubMedCentral

34.

Payne B, Chadwick T, Blamire A, Anderson K, Parikh J, Qian J, Hynes A, Wilkinson J, Price D, team EoStLRiICFiEtPs (2017) Does efavirenz replacement improve neurological function in treated HIV infection? HIV medicine 18(9):690–695CrossRef

35.

Chen Y-C, Lin C-Y, Li C-Y, Zhang Y, Ko W-C, Ko N-Y (2019) Obstructive sleep apnea among HIV-infected men in the highly active antiretroviral therapy era: a nation-wide longitudinal cohort study in Taiwan, 2000-2011. Sleep Med. https://doi.org/10.1016/j.sleep.2019.07.011

36.

Dorey-Stein Z, Amorosa VK, Kostman JR, Shannon RP (2008) Severe weight gain, lipodystrophy, dyslipidemia, and obstructive sleep apnea in a human immunodeficiency virus-infected patient following highly active antiretroviral therapy. Journal of the cardiometabolic syndrome 3(2):111–114CrossRef

37.

Schulz R, Lohmeyer J, Seeger W (2003) Obstructive sleep apnea due to HIV-associated lipodystrophy. Clin Infect Dis 37(10):1398–1399CrossRef

38.

Zhao W, Wang X, Deik AA, Hanna DB, Wang T, Haberlen SA, Shah SJ, Lazar JM, Hodis HN, Landay AL, Yu B, Gustafson D, Anastos K, Post WS, Clish CB, Kaplan RC, Qi Q (2019) Elevated plasma Ceramides are associated with antiretroviral therapy use and progression of carotid artery atherosclerosis in HIV infection. Circulation 139 (17):2003-2011. Doi:doi:https://doi.org/10.1161/CIRCULATIONAHA.118.037487

39.

Pak VM, Dai F, Keenan BT, Gooneratne NS, Pack AI (2018) Lower plasma choline levels are associated with sleepiness symptoms. Sleep Med 44:89–96. https://doi.org/10.1016/j.sleep.2017.10.004

Title: Metabolomics of sleep disorders in HIV: a narrative review
Authors: Monique Balthazar
Idiatou Diallo
Victoria M. Pak
Publication date: 01-12-2020
Publisher: Springer International Publishing
Keyword: Human Immunodeficiency Virus
Published in: Sleep and Breathing / Issue 4/2020
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-019-01993-2

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Metabolomics of sleep disorders in HIV: a narrative review

Abstract

Purpose

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2020

A pilot study in men to show the effects of postural fluid shifts on the severity of obstructive sleep apnea

TLRs and RAGE are elevated in carotid plaques from patients with moderate-to-severe obstructive sleep apnea syndrome

Metabolomics, sleepiness, and sleep duration in sleep apnea

Is cellular energy monitoring more responsive to hypoxia than pulse oximetry?

Prospective study of sleep-disordered breathing in 28 patients with acute unilateral lateral medullary infarction

Sleep disturbances and nicotine addiction:a bidirectional relationship?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page